Ionis Pharmaceuticals reiterates FY26 outlook, unchanged from April projections

Earnings

โดย Seeking Alpha·Read original

Summary · why it matters

Ionis Pharmaceuticals has reiterated its financial outlook for the full fiscal year ending December 31, 2026. The corporate guidance remains entirely unchanged from the financial projections originally provided by the company on April 29, 2026, during its first-quarter earnings release.

Ionis Pharmaceuticals Inc ±

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks

Ionis Pharmaceuticals Inc

IONS

± MixedCapitalrelevance

Company reiterates unchanged FY26 outlook, providing no new information to alter expectations.

Ionis Pharmaceuticals reiterates FY26 outlook, unchanged from April projections

Impact on stocks 1

Theme Impact

Off-coverage companies

Related news